Kristen Starbuck, MD
-
RoleGynecologic Oncology
-
Specialty
-
Research Program
-
Practicing Since2020
Background
As a gynecologic cancer specialist, Kristen D. Starbuck, MD collaborates with gynecologic cancer teams to deliver top care to patients at Emory Decatur Hospital. She specializes in the treatment of cervical, ovarian, uterine, vulvar and vaginal cancer. Dr. Starbuck is assistant professor in the Division of Gynecologic Oncology of the Department of Gynecology and Obstetrics at Emory University School of Medicine.
Titles & Roles
-
Assistant Professor, Division of Gynecologic Oncology, Department of Gynecology and ObstetricsEmory University School of Medicine
Education & Training
Education
- Fellowship, Gynecologic Oncology, 2020Roswell Park Cancer Institute
- Residency, Obstetrics & Gynecology, 2014Case Western Reserve University Metrohealth Medical Center
- Residency, Obstetrics & Gynecology, 2014Cleveland Clinic Florida
- Medical Education, MD, 2010University of Connecticut Health Center
Research
Dr. Starbuck's research focus is on glycoprotein expression in ovarian cancer and the influence of chemokines in the ovarian cancer immune microenvironment. Additional research interests include early phase and translational research, phase 2/3 clinical trials, role of immunotherapy in gynecological cancers, and patient resilience and health outcomes.
|
Publications
| Title/Journal | Authors | Publication Date |
|---|---|---|
|
Gynecologic oncology reports |
EG Thayer, ML Weirich, ZA Roecker, SE Brenner, JS Remick, AB Patel, KD Starbuck | 10/01/2024 |
|
Case report: intravenous leiomyomatosis with intracaval and intracardiac growth. European heart journal. Case reports |
DS Kikuchi, CA Goulbourne, KD Starbuck, MF Fernandes | 01/01/2023 |
|
Gynecologic oncology reports |
NS McCall, TY Eng, JW Shelton, S Hanasoge, PR Patel, AB Patel, AA McCook-Veal, JM Switchenko, TE Cole, N Khanna, CH Han, AN Gordon, KD Starbuck, JS Remick | 12/01/2022 |
|
Gynecologic oncology reports |
EV Carballo, TV Pham, G Turashvili, K Hanley, KD Starbuck, JL Meisel | 10/01/2022 |
Ratings & Reviews
Patients who are treated in outpatient and inpatient environments are eligible to receive a survey related to their individual care. Displayed ratings and reviews are displayed for Providers who have received at least 30 returned surveys over a 12-month period and are related to all Care Provider related survey questions. To help our patients better understand our Transparency program (ratings and review), the motivations behind it, how ratings are calculated, why ratings and reviews are not published for every EHC Provider, and how this information can be helpful for our patients, please click here.
| 4.9 | Provider showed concern | |
| 4.9 | Provider explained things clearly | |
| 4.9 | Provider discussed treatment options | |
| 4.9 | Provider included you in decisions | |
| 4.9 | Likelihood of recommending this provider |